A Response to William Kingston, "Streptomycin, Schatz versus Waksman, and the balance of Credit for Discovery"

  title={A Response to William Kingston, "Streptomycin, Schatz versus Waksman, and the balance of Credit for Discovery"},
  author={Milton Wainwright},
  journal={Journal of the History of Medicine and Allied Sciences},
  pages={218 - 220}
  • M. Wainwright
  • Published 1 April 2005
  • Medicine
  • Journal of the History of Medicine and Allied Sciences
PROFESSOR William Kingston (Research Associate in Business Studies, Trinity College, and Dublin) recently contributed an article to this journal relating to the controversy over the discovery of streptomycin and the respective roles played by Selman Waksman and his research student, Albert Schatz. Kingston’s article purports to be a scholarly argument against the view, largely advanced by myself, that Schatz was denied the credit for his role as codiscoverer in the discovery of this important… Expand

Topics from this paper

Is the Nobel Prize good for science?
  • A. Casadevall, F. Fang
  • Biology, Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2013
Changing the Nobel Prize to more fairly allocate credit would reduce the potential for controversy and directly benefit the scientific enterprise by promoting cooperation and collaboration of scientists within a field to reduce the negative consequences of competition between individual scientists. Expand
The treatment of tuberculosis in Ireland from the 1890s to the 1970sa case study of medical care in Leinster
In the late nineteenth century tuberculosis was endemic in Ireland being responsible for more deaths than any other single cause, but by the late 1960s the contribution of tuberculosis to mortality statistics was insignificant and a fall in mortality was spectacular. Expand
Intellectual property rights and pharmaceuticals: The case of antibiotics
The development and diffusion of antibiotics contributed to large improvements in human health and living standards. The antibiotic revolution also spawned the modern pharmaceutical industry. ThisExpand
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
In this Review, recent efforts to fight TB will be described, specifically focusing on how drug discovery could combat the resistance and persistence that make TB worthy of the moniker 'The Great White Plague'. Expand
Extensively drug-resistant tuberculosis.
Clinical manifestations, although variable in different settings and among different strains, have in general shown that XDR tuberculosis is associated with greater morbidity and mortality than non-XDR tuberculosis. Expand
History of antimicrobial drug discovery: Major classes and health impact.
  • R. Aminov
  • Biology, Medicine
  • Biochemical pharmacology
  • 2017
How the introduction of certain antimicrobial classes affected the morbidity and mortality rates due to bacterial infectious diseases in human populations is discussed. Expand
World Intellectual Property Report 2015 - Breakthrough Innovation and Economic Growth
WIPO’s latest World Intellectual Property Report (WIPR) explores the role of IP at the nexus of innovation and economic growth, focusing on the impact of breakthrough innovations. ExtraordinaryExpand
Identification and architecture of a putative secretion tube across mycobacterial outer envelope
  • Xiaoying Cai, Lei Liu, +10 authors Weimin Gong
  • Medicine
  • Science Advances
  • 2021
It is shown that Mycobacterium tuberculosis Rv3705c and its homologous MSMEG_6251 in Myc Cobacterium smegmatis are tube-forming proteins in the mycobacterial envelope (TiME), and crystallographic and cryo-EM structures show that both proteins form rotationally symmetric rings. Expand
Current pharmacotherapy of tuberculosis
V léčbě rezistentní tuberkulózy se uplatňují nová antituberkulotika a anti‐ biotika dosud využívaná spíše pro léczbu jiných infekcí. Expand


Streptomycin: discovery and resultant controversy.
  • M. Wainwright
  • Political Science, Medicine
  • History and philosophy of the life sciences
  • 1991
The aim of this essay is to discuss the streptomycin story, largely using previously unquoted archival material, and in particular to provide further evidence for the important role which Schatz played in the discovery. Expand